Skip to main content
. 2018 Dec 21;4(4):00086-2018. doi: 10.1183/23120541.00086-2018

TABLE 2.

The association between chronic obstructive pulmonary disease (COPD) and the development of peripheral arterial disease (PAD), additionally stratified by sex and smoking status

Stratification Subjects Model 1# Model 2 p-value+
Overall No PAD PAD OR (95% CI) OR (95% CI)
Overall 3123 (100) 2676 (100) 447 (100)
 Non-COPD 3038 (97.3) 2611 (97.6) 427 (95.5) Ref
 COPD 85 (2.7) 65 (2.4) 20 (5.0) 1.89 (1.13–3.18) 1.87 (1.10–3.18)
Sex 0.18
 Male
  Non-COPD 1293 (41.4) 1122 (41.9) 171 (38.3) Ref
  COPD 45 (1.4) 32 (1.2) 13 (2.9) 2.61 (1.33–5.12) 2.59 (1.04–5.16)
 Female
  Non-COPD 1745 (55.9) 1489 (55.6) 256 (57.3) Ref
  COPD 40 (1.3) 33 (1.2) 7 (1.6) 1.24 (0.54–2.87) 1.22 (0.53–2.87)
Smoking status 0.41
 Never smoker
  Non-COPD 1066 (34.1) 921 (34.4) 145 (32.4) Ref
  COPD 15 (0.5) 13 (0.5) 2 (0.4) 1.00 (0.21–4.47) 1.20 (0.26–5.57)
 Ever smoker
  Non-COPD 1972 (63.1) 1690 (63.2) 282 (63.1) Ref
  COPD 70 (2.2) 52 (1.9) 18 (4.0) 2.00 (1.14–3.50) 1.98 (1.12–3.49)

Data are presented as n (%) or ratio (95% CI). Data for smoking is represented by imputed values. Values in bold are statistically significant. OR: odds ratio; Ref: reference value. #: model 1 is adjusted for age and sex; : model 2 is adjusted for age, sex, smoking duration in pack-years, hypertension, high-density lipoprotein/cholesterol ratio and diabetes mellitus; +: p-value for interaction, calculated by adding an interaction term to model 2.